DaVita is the largest provider of dialysis services in the U.S., boasting market share levels that eclipse 35% measured by both patients and clinics. The firm operates 2,905 facilities worldwide, with 2,664 in the United States, and treats over 225,000 patients globally each year. Management began to build out a fledgling international business in 2011, but we anticipate this business will need to continue to expand before it garners the scale needed to earn attractive returns. Government payers dominate dialysis reimbursement--DaVita receives approximately 69% of U.S. sales at Medicare and Medicaid reimbursement rates, with the remaining 31% coming from commercial insurers.